Cargando…
Prospective observational study of the use of omeprazole and maropitant citrate in veterinary specialist care
The proton pump inhibitor omeprazole is administered to dogs with gastroduodenal ulceration or oesophagitis, whereas the neurokinin-1 receptor antagonist maropitant citrate is licensed as an antiemetic drug. In people, omeprazole is overprescribed in hospitals, increasing the risk of adverse effects...
Autores principales: | McCormack, Rachel, Olley, Louise, Glanemann, Barbara, Swann, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519060/ https://www.ncbi.nlm.nih.gov/pubmed/32978503 http://dx.doi.org/10.1038/s41598-020-72950-3 |
Ejemplares similares
-
Spotlight on the perioperative use of maropitant citrate
por: Hay Kraus, Bonnie L
Publicado: (2017) -
Effects of Maropitant Citrate or Acepromazine on the Incidence of Adverse Events Associated with Hydromorphone Premedication in Dogs
por: Claude, A.K., et al.
Publicado: (2014) -
Pharmacokinetics of maropitant citrate in Rhode Island Red chickens (Gallus gallus domesticus) following subcutaneous administration
por: Mones, Alissa B., et al.
Publicado: (2022) -
Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom
por: Swann, James W., et al.
Publicado: (2021) -
Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats
por: Boukaache, Youcef, et al.
Publicado: (2022)